Search Results
Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma
Dr. Sznol on Combining Nivolumab and Ipilimumab for the Treatment of Advanced Melanoma
OpACIn-neo trial RFS and biomarker analyses: optimal neoadjuvant ipi/nivo dosing in melanoma
Dr. Wolchok on Ipilimumab After Complete Resection of Stage III Melanoma
Neoadjuvant Nivolumab + Ipilimumab Could Be New SOC in Stage III Melanoma
PRADO: personalized response-driven surgery and adjuvant therapy in stage III melanoma
Success for ipilimumab and nivolumab combo in advanced melanoma
Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology
Adjuvant and Neoadjuvant Dilemmas
High- vs low-dose pre-operative ipilimumab and nivolumab in locoregionally advanced urothelial c...
Jeffrey S Weber, ASCO 2018 – Resected stage III melanoma and the CheckMate 238 trial
Ask the Expert - A Year in Review: 2022 Research Updates for the Melanoma Community
